{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:42:39Z","timestamp":1792978959793,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":1949,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1124\/jpet.119.258152","type":"journal-article","created":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T22:55:11Z","timestamp":1558738511000},"page":"593-601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":230,"title":["Nose-to-Brain Delivery"],"prefix":"10.1016","volume":"370","author":[{"given":"Zian","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai Chun","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas G.","family":"Sch\u00e4tzlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ijeoma F.","family":"Uchegbu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.119.258152_bib1","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ijpharm.2017.07.030","article-title":"Brain targeting efficiency of antimigraine drug loaded mucoadhesive intranasal nanoemulsion","volume":"529","author":"Abdou","year":"2017","journal-title":"Int J Pharm"},{"key":"10.1124\/jpet.119.258152_bib2","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1039\/C6NR07581A","article-title":"Evidence of nose-to-brain delivery of nanoemulsions: cargoes but not vehicles","volume":"9","author":"Ahmad","year":"2017","journal-title":"Nanoscale"},{"key":"10.1124\/jpet.119.258152_bib3","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1023\/A:1018967116988","article-title":"Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2)","volume":"11","author":"Artursson","year":"1994","journal-title":"Pharm Res"},{"key":"10.1124\/jpet.119.258152_bib4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/sj.npp.1301193","article-title":"Intranasal insulin improves memory in humans: superiority of insulin aspart","volume":"32","author":"Benedict","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.119.258152_bib5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.colsurfb.2017.03.035","article-title":"Nose to brain delivery in rats: effect of surface charge of rhodamine B labeled nanocarriers on brain subregion localization","volume":"154","author":"Bonaccorso","year":"2017","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1124\/jpet.119.258152_bib6","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nn0602-849","article-title":"Sniffing neuropeptides: a transnasal approach to the human brain","volume":"5","author":"Born","year":"2002","journal-title":"Nat Neurosci"},{"key":"10.1124\/jpet.119.258152_bib7","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.ymthe.2018.07.018","article-title":"Post-injury nose-to-brain delivery of Activin A and serpinB2 reduces brain damage in a mouse stroke model","volume":"26","author":"Buchthal","year":"2018","journal-title":"Mol Ther"},{"key":"10.1124\/jpet.119.258152_bib8","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1007\/s11095-012-0915-1","article-title":"Intranasal treatment of central nervous system dysfunction in humans","volume":"30","author":"Chapman","year":"2013","journal-title":"Pharm Res"},{"key":"10.1124\/jpet.119.258152_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneurol.2011.233","article-title":"Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial","volume":"69","author":"Craft","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1124\/jpet.119.258152_bib10","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3233\/JAD-161256","article-title":"Effects of regular and long-acting insulin on cognition and Alzheimer\u2019s disease biomarkers: a pilot clinical trial","volume":"57","author":"Craft","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1124\/jpet.119.258152_bib11","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1212\/WNL.50.1.164","article-title":"Cerebrospinal fluid and plasma insulin levels in Alzheimer\u2019s disease: relationship to severity of dementia and apolipoprotein E genotype","volume":"50","author":"Craft","year":"1998","journal-title":"Neurology"},{"key":"10.1124\/jpet.119.258152_bib12","first-page":"5625","article-title":"Long-term outcome in patients with recurrent malignant glioma treated with Perillyl alcohol inhalation","volume":"33","author":"Da Fonseca","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1124\/jpet.119.258152_bib13","doi-asserted-by":"crossref","first-page":"a020412","DOI":"10.1101\/cshperspect.a020412","article-title":"The blood-brain barrier","volume":"7","author":"Daneman","year":"2015","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1124\/jpet.119.258152_bib14","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"PLGA-based nanoparticles: an overview of biomedical applications","volume":"161","author":"Danhier","year":"2012","journal-title":"J Control Release"},{"key":"10.1124\/jpet.119.258152_bib15","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S1461-5347(99)00199-6","article-title":"Delivery of peptide and non-peptide drugs through the respiratory tract","volume":"2","author":"Davis","year":"1999","journal-title":"Pharm Sci Technol Today"},{"key":"10.1124\/jpet.119.258152_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4155\/tde-2018-0005","article-title":"Looking to the future of nasal drug delivery - an interview with Per Gisle Djupesland","volume":"9","author":"Djupesland","year":"2018","journal-title":"Ther Deliv"},{"key":"10.1124\/jpet.119.258152_bib17","doi-asserted-by":"crossref","first-page":"709","DOI":"10.4155\/tde.14.41","article-title":"The nasal approach to delivering treatment for brain diseases: an anatomic, physiologic, and delivery technology overview","volume":"5","author":"Djupesland","year":"2014","journal-title":"Ther Deliv"},{"key":"10.1124\/jpet.119.258152_bib18","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00431-002-1088-4","article-title":"Delay in the diagnosis of paediatric brain tumours","volume":"161","author":"Dobrovoljac","year":"2002","journal-title":"Eur J Pediatr"},{"key":"10.1124\/jpet.119.258152_bib19","first-page":"363","article-title":"Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model","volume":"6","author":"Eskandari","year":"2011","journal-title":"Int J Nanomedicine"},{"key":"10.1124\/jpet.119.258152_bib20","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/jbio.201200006","article-title":"Exploring uptake mechanisms of oral nanomedicines using multimodal nonlinear optical microscopy","volume":"5","author":"Garrett","year":"2012","journal-title":"J Biophotonics"},{"key":"10.1124\/jpet.119.258152_bib21","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S1474-4422(17)30299-5","article-title":"Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"16","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1124\/jpet.119.258152_bib22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1021\/cn200100h","article-title":"Knowledge-based, central nervous system (CNS) lead selection and lead optimization for CNS drug discovery","volume":"3","author":"Ghose","year":"2012","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/jpet.119.258152_bib23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2017.11.041","article-title":"Nanoparticulate peptide delivery exclusively to the brain produces tolerance free analgesia","volume":"270","author":"Godfrey","year":"2018","journal-title":"J Control Release"},{"key":"10.1124\/jpet.119.258152_bib24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/neuonc\/2.1.45","article-title":"The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery","volume":"2","author":"Groothuis","year":"2000","journal-title":"Neuro-oncol"},{"key":"10.1124\/jpet.119.258152_bib25","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.euroneuro.2011.08.008","article-title":"Cost of disorders of the brain in Europe 2010 [published correction appears in Eur Neuropsychopharmacol (2012) 22:237\u2013238]","volume":"21","author":"Gustavsson","year":"2011","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/jpet.119.258152_bib26","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/mp.2016.234","article-title":"Reduction of smoking urges with intranasal insulin: a randomized, crossover, placebo-controlled clinical trial","volume":"22","author":"Hamidovic","year":"2017","journal-title":"Mol Psychiatry"},{"key":"10.1124\/jpet.119.258152_bib27","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000330825","article-title":"Updated neuronal scaling rules for the brains of Glires (rodents\/lagomorphs)","volume":"78","author":"Herculano-Houzel","year":"2011","journal-title":"Brain Behav Evol"},{"key":"10.1124\/jpet.119.258152_bib28","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev.me.36.020185.002241","article-title":"The molecular mechanism of insulin action","volume":"36","author":"Kahn","year":"1985","journal-title":"Annu Rev Med"},{"key":"10.1124\/jpet.119.258152_bib29","doi-asserted-by":"crossref","first-page":"17641","DOI":"10.1038\/s41598-018-36210-9","article-title":"Effective nose-to-brain delivery of exendin-4 via coadministration with cell-penetrating peptides for improving progressive cognitive dysfunction","volume":"8","author":"Kamei","year":"2018","journal-title":"Sci Rep"},{"key":"10.1124\/jpet.119.258152_bib30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer\u2019s disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur J Neurol"},{"key":"10.1124\/jpet.119.258152_bib31","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3109\/1061186X.2015.1058802","article-title":"Cell-penetrating peptide-doxorubicin conjugate loaded NGR-modified nanobubbles for ultrasound triggered drug delivery","volume":"24","author":"Lin","year":"2016","journal-title":"J Drug Target"},{"key":"10.1124\/jpet.119.258152_bib32","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","article-title":"Intranasal delivery of biologics to the central nervous system","volume":"64","author":"Lochhead","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/jpet.119.258152_bib33","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/jcbfm.2014.215","article-title":"Rapid transport within cerebral perivascular spaces underlies widespread tracer distribution in the brain after intranasal administration","volume":"35","author":"Lochhead","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1124\/jpet.119.258152_bib34","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030","volume":"3","author":"Mathers","year":"2006","journal-title":"PLoS Med"},{"key":"10.1124\/jpet.119.258152_bib35","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2147\/IJN.S151474","article-title":"Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer\u2019s disease","volume":"13","author":"Meng","year":"2018","journal-title":"Int J Nanomedicine"},{"key":"10.1124\/jpet.119.258152_bib36","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art","volume":"50","author":"M\u00fcller","year":"2000","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1124\/jpet.119.258152_bib37","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ejpb.2018.11.002","article-title":"Oxcarbazepine free or loaded PLGA nanoparticles as effective intranasal approach to control epileptic seizures in rodents","volume":"133","author":"Musumeci","year":"2018","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1124\/jpet.119.258152_bib38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"key":"10.1124\/jpet.119.258152_bib39","doi-asserted-by":"crossref","first-page":"8119","DOI":"10.1073\/pnas.1705521114","article-title":"Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism","volume":"114","author":"Parker","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.119.258152_bib40","series-title":"Neuroscience","first-page":"342","article-title":"The olfactory epithelium and olfactory receptor neurons","author":"Purves","year":"2004"},{"key":"10.1124\/jpet.119.258152_bib41","doi-asserted-by":"crossref","first-page":"e1136","DOI":"10.1038\/tp.2017.103","article-title":"Dose-dependent social-cognitive effects of intranasal oxytocin delivered with novel Breath Powered device in adults with autism spectrum disorder: a randomized placebo-controlled double-blind crossover trial","volume":"7","author":"Quintana","year":"2017","journal-title":"Transl Psychiatry"},{"key":"10.1124\/jpet.119.258152_bib42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijbiomac.2017.12.056","article-title":"Pramipexole dihydrochloride loaded chitosan nanoparticles for nose to brain delivery: development, characterization and in vivo anti-Parkinson activity","volume":"109","author":"Raj","year":"2018","journal-title":"Int J Biol Macromol"},{"key":"10.1124\/jpet.119.258152_bib43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ab.2005.07.033","article-title":"Cell-penetrating peptides: a comparative membrane toxicity study","volume":"345","author":"Saar","year":"2005","journal-title":"Anal Biochem"},{"key":"10.1124\/jpet.119.258152_bib44","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12916-017-0801-0","article-title":"Intranasal oxytocin reduces provoked symptoms in female patients with posttraumatic stress disorder despite exerting sympathomimetic and positive chronotropic effects in a randomized controlled trial","volume":"15","author":"Sack","year":"2017","journal-title":"BMC Med"},{"key":"10.1124\/jpet.119.258152_bib45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1513\/pats.201007-050RN","article-title":"Anatomy and physiology of the upper airway","volume":"8","author":"Sahin-Yilmaz","year":"2011","journal-title":"Proc Am Thorac Soc"},{"key":"10.1124\/jpet.119.258152_bib46","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jddst.2017.11.013","article-title":"Chitosan-Mangafodipir nanoparticles designed for intranasal delivery of siRNA and DNA to brain","volume":"43","author":"Sanchez-Ramos","year":"2018","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1124\/jpet.119.258152_bib47","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12883-017-0908-0","article-title":"Nasal administration of the neuroprotective candidate NeuroEPO to healthy volunteers: a randomized, parallel, open-label safety study","volume":"17","author":"Santos-Morales","year":"2017","journal-title":"BMC Neurol"},{"key":"10.1124\/jpet.119.258152_bib48","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/jmg.2008.062141","article-title":"Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial","volume":"46","author":"Schmidt","year":"2009","journal-title":"J Med Genet"},{"key":"10.1124\/jpet.119.258152_bib49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.physbeh.2012.12.007","article-title":"Size of nostril opening as a measure of intranasal volume","volume":"110\u2013111","author":"Schriever","year":"2013","journal-title":"Physiol Behav"},{"key":"10.1124\/jpet.119.258152_bib50","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1016\/j.actbio.2011.07.025","article-title":"Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies","volume":"7","author":"Seju","year":"2011","journal-title":"Acta Biomater"},{"key":"10.1124\/jpet.119.258152_bib51","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/mp500527x","article-title":"Oral particle uptake and organ targeting drives the activity of amphotericin B nanoparticles","volume":"12","author":"Serrano","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1124\/jpet.119.258152_bib52","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijbiomac.2016.04.076","article-title":"Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route","volume":"89","author":"Shah","year":"2016","journal-title":"Int J Biol Macromol"},{"key":"10.1124\/jpet.119.258152_bib53","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11095-017-2279-z","article-title":"Formulation and in-vivo pharmacokinetic consideration of intranasal microemulsion and mucoadhesive microemulsion of rivastigmine for brain targeting","volume":"35","author":"Shah","year":"2018","journal-title":"Pharm Res"},{"key":"10.1124\/jpet.119.258152_bib54","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/npp.2015.41","article-title":"Effects of oxytocin on neural response to facial expressions in patients with schizophrenia","volume":"40","author":"Shin","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.119.258152_bib55","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1021\/mp900275s","article-title":"Transnasal delivery of methotrexate to brain tumors in rats: a new strategy for brain tumor chemotherapy","volume":"7","author":"Shingaki","year":"2010","journal-title":"Mol Pharm"},{"issue":"2","key":"10.1124\/jpet.119.258152_bib56","first-page":"ix","article-title":"Placebo\/active controlled, safety, pharmaco-kinetic\/dynamic study of INP105 (POD\u00ae olanzapine) in healthy adults: Western journal of emergency medicine: integrating emergency care with population health","volume":"20","author":"Shrewsbury","year":"2019","journal-title":"West J Emerg Med"},{"key":"10.1124\/jpet.119.258152_bib57","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1021\/mp200469a","article-title":"Enhanced oral absorption of hydrophobic and hydrophilic drugs using quaternary ammonium palmitoyl glycol chitosan nanoparticles","volume":"9","author":"Siew","year":"2012","journal-title":"Mol Pharm"},{"key":"10.1124\/jpet.119.258152_bib58","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/10717549709051892","article-title":"Olfactory absorption of insulin to the brain","volume":"4","author":"Sigurdsson","year":"1997","journal-title":"Drug Deliv"},{"key":"10.1124\/jpet.119.258152_bib59","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijpharm.2017.04.059","article-title":"Limiting the level of tertiary amines on polyamines leads to biocompatible nucleic acid vectors","volume":"526","author":"Sim\u00e3o Carlos","year":"2017","journal-title":"Int J Pharm"},{"key":"10.1124\/jpet.119.258152_bib60","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1021\/acs.molpharmaceut.7b00991","article-title":"Delivery of oxytocin to the brain for the treatment of autism spectrum disorder by nasal application","volume":"15","author":"Tanaka","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1124\/jpet.119.258152_bib61","first-page":"147","article-title":"Breath-powered sumatriptan dry nasal powder: an intranasal medication delivery system for acute treatment of migraine","volume":"11","author":"Tepper","year":"2018","journal-title":"Med Devices (Auckl)"},{"key":"10.1124\/jpet.119.258152_bib62","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuroscience.2008.01.013","article-title":"Delivery of interferon-beta to the monkey nervous system following intranasal administration","volume":"152","author":"Thorne","year":"2008","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.119.258152_bib63","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejpb.2018.02.010","article-title":"Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles","volume":"127","author":"Trotta","year":"2018","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1124\/jpet.119.258152_bib64","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/2211738502666140616184703","article-title":"The oral and intranasal delivery of propofol using chitosan amphiphile nanoparticles","volume":"2","author":"Uchegbu","year":"2014","journal-title":"Pharm Nanotech"},{"key":"10.1124\/jpet.119.258152_bib65","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/s41598-017-01279-1","article-title":"Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy","volume":"7","author":"Van Woensel","year":"2017","journal-title":"Sci Rep"},{"key":"10.1124\/jpet.119.258152_bib66","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.biopsych.2016.11.012","article-title":"Intranasal oxytocin to prevent posttraumatic stress disorder symptoms: a randomized controlled trial in emergency department patients","volume":"81","author":"van Zuiden","year":"2017","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.119.258152_bib67","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijpharm.2010.08.020","article-title":"Tight junction modulation by chitosan nanoparticles: comparison with chitosan solution","volume":"400","author":"Vllasaliu","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1124\/jpet.119.258152_bib68","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1208\/s12248-017-0179-0","article-title":"Demonstration of direct nose-to-brain transport of unbound HIV-1 replication inhibitor DB213 via intranasal administration by pharmacokinetic modeling","volume":"20","author":"Wang","year":"2017","journal-title":"AAPS J"},{"key":"10.1124\/jpet.119.258152_bib69","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.peptides.2012.07.029","article-title":"Effect of intranasal arginine vasopressin on human headache","volume":"38","author":"Yang","year":"2012","journal-title":"Peptides"},{"key":"10.1124\/jpet.119.258152_bib70","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jconrel.2018.07.020","article-title":"Focused ultrasound combined with microbubble-mediated intranasal delivery of gold nanoclusters to the brain","volume":"286","author":"Ye","year":"2018","journal-title":"J Control Release"},{"key":"10.1124\/jpet.119.258152_bib71","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijpharm.2013.11.049","article-title":"Intranasal nanoparticles of basic fibroblast growth factor for brain delivery to treat Alzheimer\u2019s disease","volume":"461","author":"Zhang","year":"2014","journal-title":"Int J Pharm"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652426033X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652426033X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.119.258152","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T16:53:44Z","timestamp":1740675224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652426033X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S002235652426033X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.119.258152","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nose-to-Brain Delivery","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.119.258152","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by The Author(s)","name":"copyright","label":"Copyright"}]}}